With the proposal of " "Healthy China 2030" Planning Outline ", China's medical device industry development has entered a golden period, thanks to the assistance and support of the domestic large market and the global supply system, and is also closely related to the hard work of local enterprises in R&D. With the upgrading of equipment and the integration of industries, there have been substantial changes in the field of high-end equipment, and a number of representative companies have emerged, and they have taken a big step in the process of domestic substitution.
As a "unicorn" in the field of intervention, Weimai Medical has attracted the attention of professionals at the 2022 China International Medical Device Expo (CMEF) held on November 23.
With the development of medical technology, the accuracy of surgery has also improved. Among them, interventional treatment of has the advantages of precision and minimally invasiveness, and has gradually been valued by many doctors and patients. However, interventional treatment also has its disadvantages. Doctors need to be exposed to X-ray for a long time. Although doctors can wear lead-clothing for surgery, long-term radiation in their career may still seriously affect the health of doctors.
Weimai Medical CEO Yang He introduced this: Excessive X ray is very harmful to the human body. The amount of surgery that Chinese doctors need to complete in a day is very high, and the workload is far three to four times that of the world average. When the doctor performs surgery next to the bed, he suffers great damage to the body by rays.
In this context, "not delaying the surgical effect, but enabling doctors to operate safely under radial conditions" has become a common demand in the industry, and the birth of interventional robots has greatly changed the status quo. It has achieved the interventional doctor to complete the interventional surgery under ray-free conditions, completely getting rid of X-ray radiation damage, and greatly improving the health level of the interventional doctor.
At the same time, doctors do not need to wear bulky lead clothes, avoiding occupational diseases such as dislocation of shoulder, neck and lumbar spine strain, and greatly improving the doctor's surgical environment. In the 5G technology era, through interventional robot ETcath and remote interventional surgery control system, doctors can truly realize remote and remote surgery.
In October 2021, the ETcath vascular interventional surgery robot was operated by Professor Zhou Yujie's team to complete the first PCI (percutaneous coronary interventional surgery) of the domestic interventional robot at Anzhen Hospital Affiliated to Capital Medical University, achieving a complete success. In September 2022, Weimai Medical ETcath interventional surgical robot was approved to enter the National Special Review Procedure for Innovative Medical Devices (Green Channel), becoming the first domestic self-developed interventional surgical robot to enter the Special Review Procedure for Innovative Medical Devices in China.
It is reported that in 2023, Weimai Medical will launch a variety of tablets of different sizes, adapt to more surgical types such as the heart, peripherals, and launch a dedicated model of complex operating room DSA. Combined with interventional surgery robots and AI image processing platforms, it will fully present a "eye, hand, and brain" integrated medical solution and apply it to clinical practice, providing surgeons with more intelligent, convenient and efficient surgical support, thus bringing patients a safer surgical environment and better solving the disease.
Xiaoxiang Morning News reporter Mei Mei
News clues and leaks channel: Download the "Chen Video" client in the application market and enter the "Chenyi Help" special topic; or call the Chen Video News Hotline 0731-85571188.